InnoTherapy Inc (246960) - Total Liabilities

Latest as of September 2025: ₩50.78 Billion KRW ≈ $34.41 Million USD

Based on the latest financial reports, InnoTherapy Inc (246960) has total liabilities worth ₩50.78 Billion KRW (≈ $34.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

InnoTherapy Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how InnoTherapy Inc's total liabilities have evolved over time, based on quarterly financial data. See InnoTherapy Inc (246960) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

InnoTherapy Inc Competitors by Total Liabilities

The table below lists competitors of InnoTherapy Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Xref Ltd AU:XF1	Australia	AU$20.19 Million
WF Holding Limited Ordinary Shares NASDAQ:WFF	USA	$6.64 Million
LEADING HOLDINGS DL-01 F:88Z	Germany	€22.46 Billion
Qwamplify SA PA:ALQWA	France	€29.17 Million
The European Smaller Companies Trust PLC LSE:ESCT	UK	GBX51.16 Million
The Global Smaller Companies Trust Plc LSE:GSCT	UK	GBX54.09 Million
Finsbury Growth & Income Trust LSE:FGT	UK	GBX33.77 Million
Hanson International Tbk JK:MYRX	Indonesia	Rp4.40 Trillion

Liability Composition Analysis (2015–2024)

This chart breaks down InnoTherapy Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 246960 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.96	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.67	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how InnoTherapy Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for InnoTherapy Inc (2015–2024)

The table below shows the annual total liabilities of InnoTherapy Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩8.54 Billion ≈ $5.79 Million	-24.12%
2023-12-31	₩11.26 Billion ≈ $7.63 Million	-36.66%
2022-12-31	₩17.77 Billion ≈ $12.04 Million	-18.50%
2021-12-31	₩21.80 Billion ≈ $14.78 Million	+394.60%
2020-12-31	₩4.41 Billion ≈ $2.99 Million	+105.02%
2019-12-31	₩2.15 Billion ≈ $1.46 Million	+29.66%
2018-12-31	₩1.66 Billion ≈ $1.12 Million	+49.76%
2017-12-31	₩1.11 Billion ≈ $750.44K	+15.60%
2016-12-31	₩957.90 Million ≈ $649.16K	-93.32%
2015-12-31	₩14.34 Billion ≈ $9.72 Million	--

About InnoTherapy Inc

KQ:246960 Korea Medical Devices

Market Cap

$10.27 Million

₩15.15 Billion KRW

Market Cap Rank

#26982 Global

#1969 in Korea

Share Price

₩1784.00

Change (1 day)

-3.52%

52-Week Range

₩1672.00 - ₩12440.00

All Time High

₩25350.00